- Open Access
Mitochondria as signaling organelles
© Chandel; licensee BioMed Central Ltd. 2014
Received: 22 April 2014
Published: 27 May 2014
Almost 20 years ago, the discovery that mitochondrial release of cytochrome c initiates a cascade that leads to cell death brought about a wholesale change in how cell biologists think of mitochondria. Formerly viewed as sites of biosynthesis and bioenergy production, these double membrane organelles could now be thought of as regulators of signal transduction. Within a few years, multiple other mitochondria-centric signaling mechanisms have been proposed, including release of reactive oxygen species and the scaffolding of signaling complexes on the outer mitochondrial membrane. It has also been shown that mitochondrial dysfunction causes induction of stress responses, bolstering the idea that mitochondria communicate their fitness to the rest of the cell. In the past decade, multiple new modes of mitochondrial signaling have been discovered. These include the release of metabolites, mitochondrial motility and dynamics, and interaction with other organelles such as endoplasmic reticulum in regulating signaling. Collectively these studies have established that mitochondria-dependent signaling has diverse physiological and pathophysiological outcomes. This review is a brief account of recent work in mitochondria-dependent signaling in the historical framework of the early studies.
Hans Krebs won the Nobel Prize in Physiology or Medicine in 1953 for his discovery of the citric acid cycle. In his Nobel Lecture, Krebs stated, ‘that in some micro-organisms the cycle primarily supplies intermediates rather than energy, whilst in the animal and most other organisms it supplies both energy and intermediates’. This essentially describes the two salient functions of mitochondria described in most biochemistry textbooks: production of ATP, and the generation of intermediary metabolites. The citric acid cycle, commonly referred to as the TCA cycle, generates metabolites and reducing equivalents (NADH and FADH2). Electrons from reducing equivalents feed into the mitochondrial electron transport chain (ETC), which pumps protons across the mitochondrial inner membrane to generate an electrochemical gradient that is required both for production of ATP and for the efficient shuttling of proteins into and out of mitochondria. Mitochondrial ATP generation allows cells to maintain a high ATP/ADP ratio, which is necessary to thermodynamically drive many biochemical reactions. Mitochondria are also involved in the generation of proteins that contain heme and porphyrin moieties, a process dependent on membrane potential. The metabolites generated by the TCA cycle are precursors to the biosynthesis of many macromolecules, including lipids, carbohydrates, proteins and nucleotides. Thus, mitochondria have historically been viewed as bioenergetic and biosynthetic organelles; however, mitochondrial genetics has demonstrated that alterations in proteins that have similar effects on TCA cycle and ETC activity often yield divergent phenotypes, suggesting that mitochondrial perturbation must manifest beyond biosynthesis and bioenergetics.
Mitochondrial cytochrome c release regulates signaling
In the mid-1990s, the biology related to mitochondrial genetics was an exciting and rapidly evolving field. Mitochondria contain their own genome, which encodes a small percentage of mitochondrial proteins, with the majority encoded by nuclear DNA. How mitochondrial DNA integrates with nuclear DNA to make cells function and how miscommunication between the two types of DNA can lead to pathology continues to be a fascinating question . By contrast, there was a sense that every question related to the biochemistry of mitochondria had been answered. The field’s best days were in the past. Nevertheless, I had pursued a PhD on the oxygen dependence of cytochrome c oxidase [9, 10] because I thought there might be interesting biochemistry under limiting oxygen conditions (hypoxia), a condition prominent in tumors, ischemic diseases and during development in utero. Thus, it came as a complete surprise when in 1996 Xiaodong Wang and colleagues, using biochemical approaches, reported that cytochrome c is released from mitochondria to initiate cell death in mammalian cells . Cytochrome c is an electron carrier in the mitochondria and is an essential component of the electron transport chain, and ultimately necessary for ATP generation. To me, this seemed an extraordinarily important discovery in research on mitochondria. It reenergized interest not only in the biochemical activities of mitochondria, but also in how this organelle is integrated with the rest of the cell. Soon multiple labs around the world were examining the mechanisms leading to release of cytochrome c in cells that have been instructed to die [11–13]. This led to the examination of mitochondrial ATP generation, membrane potential, and oxygen consumption in cells committed to death - all of which were things I understood. But, beyond its seminal role in cell death, the discovery of the apoptotic release of cytochrome c opened the possibility that there might be other mechanisms by which mitochondria communicate with the cell, especially under physiological conditions. It was difficult to imagine that mitochondria would play a signaling role only under conditions leading to cell death.
Mitochondrial ROS regulate signaling
In the mid-1990s, NADPH oxidase activity had been demonstrated to promote signaling pathways involved in cell proliferation through oxidation of particular cysteine residues in proteins, modulating their activity [14–16]. By contrast, mitochondrial ROS (mROS) were proposed to be produced only under pathological conditions to invoke damage . However, in the late 1990s, mROS emerged as signaling molecules that communicate between mitochondria and the rest of the cell under physiological conditions. An early example of this retrograde signaling under physiological conditions is the observation that hypoxic conditions stimulate mitochondria to release ROS, resulting in the stabilization of hypoxia inducible factors (HIFs) and the induction of genes responsible for metabolic adaptation to low oxygen [2, 18]. Subsequently, mROS were shown to regulate cellular metabolism and tumor necrosis factor receptor signaling [19–21]. Eight sites in the mitochondrial inner membrane and matrix have been implicated in the production of ROS . The factors that control mROS production include the concentration of oxygen available to mitochondria, the redox state of the different electron transport chain complexes and mitochondrial membrane potential . In the past decade, mROS have been shown to regulate a wide range of biological processes, including oxygen sensing, epigenetics, autophagy, innate and adaptive immune responses, stem cell proliferation and differentiation, and hormone signaling [24–28].
A scientific colleague and friend once quipped, ‘If you don’t have a mechanism just say it is ROS’. There is some justification for this remark, since ROS have been linked to a wide variety of biological outcomes, including proliferation, differentiation, metabolic adaptation and senescence, though with no insight into the specific mROS targets required to invoke such diverse biological outcomes, or the mechanism involved. It is important to note that mROS targets that relay signaling could be localized in any or all of the mitochondrial matrix, the intermembrane space, or the cytosol. Furthermore, given the reactivity and toxicity of ROS at high levels, it seems likely that lower levels of mROS may be generated that invoke distinct biological outcomes. Control of different stem cell fates by ROS is an example of different levels of ROS invoking different biological outcomes. The two salient features of stem cells are their ability to self-renew, and their ability to differentiate into specialized tissues [29, 30]. An emerging model is that quiescent stem cells reside at low levels of ROS and slight increases in ROS are necessary signals for self-renewal and cellular differentiation [31–33]. ROS levels above those required for self-renewal or differentiation impair these critical two stem cell properties and result in stem cell hyper-proliferation, resulting in stem cell exhaustion . Going forward, it will be important to systematically quantify the ROS levels generated by mitochondria and their targets that are necessary for stem cell proliferation, differentiation and exhaustion in a given stem cell model system.
One interesting development over the past two decades has been the change in perspective on the role of mROS signaling in aging. Originally the free radical theory of aging proposed that, during the aging process, damaged mitochondria produced increasing amounts of ROS leading to tissue damage . However, in most studies antioxidants have not extended lifespan of model organisms and clinical trials using antioxidants in humans have not shown any beneficial effects on age-related diseases . On the contrary, recent evidence in yeast, Caenorhabditis elegans, and mice suggests that increasing mitochondrial generation of ROS can activate cellular stress pathways to dampen tissue degeneration, promote healthy aging and increase lifespan [37–40]. Based on the studies from the past two decades, an emerging model of mROS and signaling suggests that low levels (picomolar to nanomolar range) of mROS are necessary to maintain homeostatic biological processes, while slightly elevated levels of mROS initiate pathways for adaptation to stress. Much higher levels of mROS trigger cell death or senescence.
Mitochondrial outer membrane as a platform for signaling
In the mid-1990s it was shown that AKAPs could be tethered to the outer mitochondrial membrane and, in subsequent years, the targeting motifs needed for AKAP binding to outer mitochondrial membrane were elucidated [4, 41]. AKAPs bind to the cAMP-dependent serine/threonine kinase PKA and assemble PKA with multiple signaling proteins on a scaffold to generate a signaling hub, which can be targeted to various subcellular localizations to allow specific targeting of PKA-dependent signaling . The biological significance of AKAP tethering to mitochondria was demonstrated in the late 1990s when it was shown that survival factors induce PKA-dependent phosphorylation and inactivation of BAD, a proapoptotic Bcl2 family member, specifically bound to outer mitochondrial membrane . Beyond apoptosis, recent studies demonstrate that BAD tethering to mitochondria also regulates organismal glucose homeostasis [43, 44]. In the past decade, mitochondria-bound PKA-AKAP assemblies have been shown to regulate oxidative metabolism, the mitochondrial fission/fusion machinery, and hypoxic responses [45, 46]. This allows cellular signaling pathways to converge on the mitochondrial PKA-AKAP axis to control mitochondrial function. AKAPs have been shown to not only anchor PKA, but also act as scaffolding proteins to coordinate the activity of many other signaling enzymes such as kinases and phosphatases . Thus, it is likely that there are multiple other AKAP-dependent but PKA-independent signaling pathways tethered to the outer mitochondrial membrane that remain to be discovered.
The mitochondrial outer membrane also serves as a scaffold for complexes regulating immune responses. This was first highlighted in the mid-2000s by the identification of mitochondrial antiviral signaling protein (MAVS), a crucial adaptor for RIG-I-like receptor signaling . RIG-I recognizes single-stranded viral RNA and subsequently activates type I interferon production through MAVS, which is localized to the outer mitochondrial membrane [49, 50]. Type-I interferons (IFNα/β) are secreted very soon after virus infection. Infected cells generate IFNβ followed shortly by the production of IFNα. Type I interferons activate interferon-stimulated genes (ISGs) as well as the NF-κB pathway. ISGs encode anti-viral proteins that produce an anti-viral state in surrounding cells in close proximity to the infected cells, to limit the spread of the virus. The activation of the NK-κB pathway leads to the production of several proinflammatory cytokines and chemokines that lead to infiltration of circulating innate cells and eventually adaptive immune T and B cells. This helps control the viral infection . Recently, other innate immune molecules involved in NOD-like receptor (NLR) and TOLL-like receptor (TLR) signaling have been functionally associated with the outer mitochondrial membrane [52–54]. Exactly why these immune complexes require localization to the outer mitochondrial membrane is not fully understood . Mitochondria-generated ROS are necessary for optimal function of many immune responses, and thus proximity to ROS production could be one reason why immune complexes are tethered to the outer mitochondrial membrane [56, 57]. It is interesting that mitochondria are evolutionarily related to alpha-proteobacteria, and thus are descended from symbiotic pathogens. We continue to be dependent on our own pathogen - mitochondria - to mount optimal responses against foreign pathogens.
Mitochondrial dysfunction and signaling
Emerging modes of communication between mitochondria and the cell
In the past few years, other interesting modes of communication between mitochondria and the rest of the cell have been discovered. These include release of metabolites, activation of AMPK, and changes in mitochondrial dynamics. Briefly I will highlight these lively new areas. Metabolite availability has emerged as an important mechanism to control signal transduction, notably the acetylation and methylation of DNA and histones regulating epigenetics . Mitochondria generate much of the acetyl-CoA and S-Adenosylmethionine (SAM) needed for protein acetylation and methylation, respectively. Thus, changes in mitochondrial biology can have profound effects on the epigenetic state [67–69]. Metabolic enzymes can also undergo acetylation at specific residues that affect their catalytic function . Loss of ATP production by mitochondria (for example, during ischemia) can also regulate signaling through increasing levels of AMP and its breakdown product adenosine. The increase in AMP levels concomitant with a decrease in ATP levels activates the kinase AMPK, which halts multiple anabolic processes (metabolic demand) in the cell and promotes catabolic processes such as autophagy to ensure ample metabolic supply . Adenosine can be released from cells where it engages in activation of G-protein-coupled receptors [72, 73]. Thus, metabolites and adenine nucleotides typically thought of being involved in biosynthetic and bioenergetic processes are also actively involved in signaling.
The cell biology of mitochondria has rapidly evolved in the past decade, bringing about the new field of mitochondrial dynamics . While the molecular details of how mitochondria move throughout the cell are still being elucidated, it is known that the ability of mitochondria to properly move around in the cell is required to properly disseminate their signals to the correct targets . For example, hypoxia causes mitochondria to cluster into the perinuclear region, allowing release of ROS into the nucleus for optimal hypoxic gene expression . Mitochondria in healthy cells tend to be elongated and fuse together into ‘spaghetti’ like filamentous structures. The rate of fusion and fission of mitochondria is tightly controlled . Excessive fission disrupts these filamentous networks, resulting in a punctate pattern and mitochondrial dysfunction. A recent study highlights how the fission/fusion machinery integrates with cellular signaling to dictate biological outcomes. The disruption of fusion in mouse embryonic heart and in embryonic stem cells results in disruption of mouse heart development and impaired differentiation of embryonic stem cells into cardiomyocytes due to increased Ca2+-dependent calcineurin activity and Notch1 signaling .
Lastly, mitochondria tether to specific subdomains of the endoplasmic reticulum (ER) referred to as mitochondria-associated membranes or MAMs . Initially, MAMs were shown to be necessary for rapid transmission of calcium (Ca2+) signals between the ER and mitochondria to regulate intracellular calcium levels . Recent studies have demonstrated that MAMs regulate mitochondrial motility and shape, ROS and ATP production, autophagy, ER stress and immune signaling .
In the past decade, there has been an explosion of scientific inquiry in the areas of mitochondrial genetics, cell biology and biochemistry . Work in these fields is increasingly converging on the control of signaling events in the rest of the cell, with important implications for regulation of physiology and common diseases. Although much has been deciphered about the types of signaling modes whereby mitochondria communicate with the rest of the cell, the molecular details remain sparse. A better understanding of the underlying mechanisms will hopefully yield insight into how to alleviate common diseases such as diabetes, cancer, and neurodegeneration, as well as provide insight into the early evolution of eukaryotes.
I would like to thank Dr Robert Hamanka for his excellent comments on this review. This work is supported by R01CA123067 and 5P01HL071643.
- Liu X, Kim CN, Yang J, Jemmerson R, Wang X: Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell. 1996, 86: 147-157. 10.1016/S0092-8674(00)80085-9.PubMedView ArticleGoogle Scholar
- Chandel N, Maltepe E, Goldwasser E, Mathieu C, Simon M, Schumacker P: Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci U S A. 1998, 95: 11715-11720. 10.1073/pnas.95.20.11715.PubMed CentralPubMedView ArticleGoogle Scholar
- Harada H, Becknell B, Wilm M, Mann M, Huang LJ, Taylor SS, Scott JD, Korsmeyer SJ: Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. Mol Cell. 1999, 3: 413-422. 10.1016/S1097-2765(00)80469-4.PubMedView ArticleGoogle Scholar
- Chen Q, Lin RY, Rubin CS: Organelle-specific targeting of protein kinase AII (PKAII). Molecular and in situ characterization of murine A kinase anchor proteins that recruit regulatory subunits of PKAII to the cytoplasmic surface of mitochondria. J Biol Chem. 1997, 272: 15247-15257. 10.1074/jbc.272.24.15247.PubMedView ArticleGoogle Scholar
- Martinus RD, Garth GP, Webster TL, Cartwright P, Naylor DJ, Hoj PB, Hoogenraad NJ: Selective induction of mitochondrial chaperones in response to loss of the mitochondrial genome. Eur J Biochem. 1996, 240: 98-103. 10.1111/j.1432-1033.1996.0098h.x.PubMedView ArticleGoogle Scholar
- Biswas G, Adebanjo OA, Freedman BD, Anandatheerthavarada HK, Vijayasarathy C, Zaidi M, Kotlikoff M, Avadhani NG: Retrograde Ca2+ signaling in C2C12 skeletal myocytes in response to mitochondrial genetic and metabolic stress: a novel mode of inter-organelle crosstalk. EMBO J. 1999, 18: 522-533. 10.1093/emboj/18.3.522.PubMed CentralPubMedView ArticleGoogle Scholar
- Rizzuto R, Brini M, Murgia M, Pozzan T: Microdomains with high Ca2+ close to IP3-sensitive channels that are sensed by neighboring mitochondria. Science. 1993, 262: 744-747. 10.1126/science.8235595.PubMedView ArticleGoogle Scholar
- Wallace D: A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet. 2005, 39: 359-407. 10.1146/annurev.genet.39.110304.095751.PubMed CentralPubMedView ArticleGoogle Scholar
- Chandel NS, Budinger GR, Schumacker PT: Molecular oxygen modulates cytochrome c oxidase function. J Biol Chem. 1996, 271: 18672-18677. 10.1074/jbc.271.31.18672.PubMedView ArticleGoogle Scholar
- Chandel N, Budinger G, Choe S, Schumacker P: Cellular respiration during hypoxia. Role of cytochrome oxidase as the oxygen sensor in hepatocytes. J Biol Chem. 1997, 272: 18808-18816. 10.1074/jbc.272.30.18808.PubMedView ArticleGoogle Scholar
- Vander Heiden MG, Chandel NS, Williamson EK, Schumacker PT, Thompson CB: Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell. 1997, 91: 627-637. 10.1016/S0092-8674(00)80450-X.PubMedView ArticleGoogle Scholar
- Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD: The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 1997, 275: 1132-1136. 10.1126/science.275.5303.1132.PubMedView ArticleGoogle Scholar
- Gross A, Jockel J, Wei MC, Korsmeyer SJ: Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J. 1998, 17: 3878-3885. 10.1093/emboj/17.14.3878.PubMed CentralPubMedView ArticleGoogle Scholar
- Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, Fearon ER, Sundaresan M, Finkel T, Goldschmidt-Clermont PJ: Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science. 1997, 275: 1649-1652. 10.1126/science.275.5306.1649.PubMedView ArticleGoogle Scholar
- Sundaresan M, Yu Z, Ferrans V, Irani K, Finkel T: Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science. 1995, 270: 296-299. 10.1126/science.270.5234.296.PubMedView ArticleGoogle Scholar
- Bae YS, Kang SW, Seo MS, Baines IC, Tekle E, Chock PB, Rhee SG: Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J Biol Chem. 1997, 272: 217-221. 10.1074/jbc.272.1.217.PubMedView ArticleGoogle Scholar
- Shigenaga MK, Hagen TM, Ames BN: Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci U S A. 1994, 91: 10771-10778. 10.1073/pnas.91.23.10771.PubMed CentralPubMedView ArticleGoogle Scholar
- Chandel NS, McClintock DS, Feliciano CE, Wood TM, Melendez JA, Rodriguez AM, Schumacker PT: Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing. J Biol Chem. 2000, 275: 25130-25138. 10.1074/jbc.M001914200.PubMedView ArticleGoogle Scholar
- Chandel N, Trzyna W, McClintock D, Schumacker P: Role of oxidants in NF-kappa B activation and TNF-alpha gene transcription induced by hypoxia and endotoxin. J Immunol. 2000, 165: 1013-1021. 10.4049/jimmunol.165.2.1013.PubMedView ArticleGoogle Scholar
- Chandel N, Schumacker P, Arch R: Reactive oxygen species are downstream products of TRAF-mediated signal transduction. J Biol Chem. 2001, 276: 42728-42736. 10.1074/jbc.M103074200.PubMedView ArticleGoogle Scholar
- Nemoto S, Takeda K, Yu ZX, Ferrans VJ, Finkel T: Role for mitochondrial oxidants as regulators of cellular metabolism. Mol Cell Biol. 2000, 20: 7311-7318. 10.1128/MCB.20.19.7311-7318.2000.PubMed CentralPubMedView ArticleGoogle Scholar
- Brand MD: The sites and topology of mitochondrial superoxide production. Exp Gerontol. 2010, 45: 466-472. 10.1016/j.exger.2010.01.003.PubMed CentralPubMedView ArticleGoogle Scholar
- Murphy M: How mitochondria produce reactive oxygen species. Biochem J. 2009, 417: 1-13. 10.1042/BJ20081386.PubMed CentralPubMedView ArticleGoogle Scholar
- West AP, Shadel GS, Ghosh S: Mitochondria in innate immune responses. Nat Rev Immunol. 2011, 11: 389-402. 10.1038/nri2975.PubMed CentralPubMedView ArticleGoogle Scholar
- Schroeder EA, Raimundo N, Shadel GS: Epigenetic silencing mediates mitochondria stress-induced longevity. Cell Metab. 2013, 17: 954-964. 10.1016/j.cmet.2013.04.003.PubMed CentralPubMedView ArticleGoogle Scholar
- Collins Y, Chouchani ET, James AM, Menger KE, Cocheme HM, Murphy MP: Mitochondrial redox signalling at a glance. J Cell Sci. 2012, 125: 801-806. 10.1242/jcs.098475.PubMedView ArticleGoogle Scholar
- Sena LA, Chandel NS: Physiological roles of mitochondrial reactive oxygen species. Mol Cell. 2012, 48: 158-167. 10.1016/j.molcel.2012.09.025.PubMed CentralPubMedView ArticleGoogle Scholar
- Hamanaka R, Chandel N: Mitochondrial reactive oxygen species regulate hypoxic signaling. Curr Opin Cell Biol. 2009, 21: 894-899. 10.1016/j.ceb.2009.08.005.PubMed CentralPubMedView ArticleGoogle Scholar
- Sahin E, Depinho RA: Linking functional decline of telomeres, mitochondria and stem cells during ageing. Nature. 2010, 464: 520-528. 10.1038/nature08982.PubMed CentralPubMedView ArticleGoogle Scholar
- Signer RA, Morrison SJ: Mechanisms that regulate stem cell aging and life span. Cell Stem Cell. 2013, 12: 152-165. 10.1016/j.stem.2013.01.001.PubMed CentralPubMedView ArticleGoogle Scholar
- Liu J, Finkel T: Stem cells and oxidants: too little of a bad thing. Cell Metab. 2013, 18: 1-2. 10.1016/j.cmet.2013.06.007.PubMed CentralPubMedView ArticleGoogle Scholar
- Xu X, Duan S, Yi F, Ocampo A, Liu GH, JC IB: Mitochondrial regulation in pluripotent stem cells. Cell Metab. 2013, 18: 325-332. 10.1016/j.cmet.2013.06.005.PubMedView ArticleGoogle Scholar
- Hamanaka RB, Glasauer A, Hoover P, Yang S, Blatt H, Mullen AR, Getsios S, Gottardi CJ, DeBerardinis RJ, Lavker RM, Chandel NS: Mitochondrial reactive oxygen species promote epidermal differentiation and hair follicle development. Sci Signal. 2013, 6: ra8-PubMed CentralPubMedView ArticleGoogle Scholar
- Liu J, Cao L, Finkel T: Oxidants, metabolism, and stem cell biology. Free Radic Biol Med. 2011, 51: 2158-2162. 10.1016/j.freeradbiomed.2011.10.434.PubMed CentralPubMedView ArticleGoogle Scholar
- Harman D: Aging: a theory based on free radical and radiation chemistry. J Gerontol. 1956, 11: 298-300. 10.1093/geronj/11.3.298.PubMedView ArticleGoogle Scholar
- Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C: Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA. 2007, 297: 842-857. 10.1001/jama.297.8.842.PubMedView ArticleGoogle Scholar
- Ristow M, Schmeisser S: Extending life span by increasing oxidative stress. Free Radic Biol Med. 2011, 51: 327-336. 10.1016/j.freeradbiomed.2011.05.010.PubMedView ArticleGoogle Scholar
- Hekimi S, Lapointe J, Wen Y: Taking a ‘good’ look at free radicals in the aging process. Trends Cell Biol. 2011, 21: 569-576. 10.1016/j.tcb.2011.06.008.PubMed CentralPubMedView ArticleGoogle Scholar
- Liu X, Jiang N, Hughes B, Bigras E, Shoubridge E, Hekimi S: Evolutionary conservation of the clk-1-dependent mechanism of longevity: loss of mclk1 increases cellular fitness and lifespan in mice. Genes Dev. 2005, 19: 2424-2434. 10.1101/gad.1352905.PubMed CentralPubMedView ArticleGoogle Scholar
- Schulz TJ, Zarse K, Voigt A, Urban N, Birringer M, Ristow M: Glucose restriction extends Caenorhabditis elegans life span by inducing mitochondrial respiration and increasing oxidative stress. Cell Metab. 2007, 6: 280-293. 10.1016/j.cmet.2007.08.011.PubMedView ArticleGoogle Scholar
- Huang LJ, Wang L, Ma Y, Durick K, Perkins G, Deerinck TJ, Ellisman MH, Taylor SS: NH2-Terminal targeting motifs direct dual specificity A-kinase-anchoring protein 1 (D-AKAP1) to either mitochondria or endoplasmic reticulum. J Cell Biol. 1999, 145: 951-959. 10.1083/jcb.145.5.951.PubMed CentralPubMedView ArticleGoogle Scholar
- Taylor SS, Zhang P, Steichen JM, Keshwani MM, Kornev AP: PKA: lessons learned after twenty years. Biochim Biophys Acta. 1834, 2013: 1271-1278.Google Scholar
- Gimenez-Cassina A, Garcia-Haro L, Choi CS, Osundiji MA, Lane EA, Huang H, Yildirim MA, Szlyk B, Fisher JK, Polak K, Patton E, Wiwczar J, Godes M, Lee DH, Robertson K, Kim S, Kulkarni A, Distefano A, Samuel V, Cline G, Kim YB, Shulman GI, Danial NN: Regulation of hepatic energy metabolism and gluconeogenesis by BAD. Cell Metab. 2014, 19: 272-284. 10.1016/j.cmet.2013.12.001.PubMed CentralPubMedView ArticleGoogle Scholar
- Danial NN, Walensky LD, Zhang CY, Choi CS, Fisher JK, Molina AJ, Datta SR, Pitter KL, Bird GH, Wikstrom JD, Deeney JT, Robertson K, Morash J, Kulkarni A, Neschen S, Kim S, Greenberg ME, Corkey BE, Shirihai OS, Shulman GI, Lowell BB, Korsmeyer SJ: Dual role of proapoptotic BAD in insulin secretion and beta cell survival. Nat Med. 2008, 14: 144-153. 10.1038/nm1717.PubMed CentralPubMedView ArticleGoogle Scholar
- Carlucci A, Lignitto L, Feliciello A: Control of mitochondria dynamics and oxidative metabolism by cAMP, AKAPs and the proteasome. Trends Cell Biol. 2008, 18: 604-613. 10.1016/j.tcb.2008.09.006.PubMedView ArticleGoogle Scholar
- Kim H, Scimia MC, Wilkinson D, Trelles RD, Wood MR, Bowtell D, Dillin A, Mercola M, Ronai ZA: Fine-tuning of Drp1/Fis1 availability by AKAP121/Siah2 regulates mitochondrial adaptation to hypoxia. Mol Cell. 2011, 44: 532-544. 10.1016/j.molcel.2011.08.045.PubMed CentralPubMedView ArticleGoogle Scholar
- Esseltine JL, Scott JD: AKAP signaling complexes: pointing towards the next generation of therapeutic targets?. Trends Pharmacol Sci. 2013, 34: 648-655. 10.1016/j.tips.2013.10.005.PubMedView ArticleGoogle Scholar
- Seth RB, Sun L, Ea CK, Chen ZJ: Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell. 2005, 122: 669-682. 10.1016/j.cell.2005.08.012.PubMedView ArticleGoogle Scholar
- Koshiba T: Mitochondrial-mediated antiviral immunity. Biochim Biophys Acta. 1833, 2013: 225-232.Google Scholar
- Belgnaoui SM, Paz S, Hiscott J: Orchestrating the interferon antiviral response through the mitochondrial antiviral signaling (MAVS) adapter. Curr Opin Immunol. 2011, 23: 564-572. 10.1016/j.coi.2011.08.001.PubMedView ArticleGoogle Scholar
- Takeuchi O, Akira S: Pattern recognition receptors and inflammation. Cell. 2010, 140: 805-820. 10.1016/j.cell.2010.01.022.PubMedView ArticleGoogle Scholar
- West AP, Brodsky IE, Rahner C, Woo DK, Erdjument-Bromage H, Tempst P, Walsh MC, Choi Y, Shadel GS, Ghosh S: TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature. 2011, 472: 476-480. 10.1038/nature09973.PubMed CentralPubMedView ArticleGoogle Scholar
- Zhou R, Yazdi AS, Menu P, Tschopp J: A role for mitochondria in NLRP3 inflammasome activation. Nature. 2011, 469: 221-225. 10.1038/nature09663.PubMedView ArticleGoogle Scholar
- Robbins GR, Wen H, Ting JP: Inflammasomes and metabolic disorders: old genes in modern diseases. Mol Cell. 2014, 54: 297-308. 10.1016/j.molcel.2014.03.029.PubMed CentralPubMedView ArticleGoogle Scholar
- Arnoult D, Soares F, Tattoli I, Girardin SE: Mitochondria in innate immunity. EMBO Rep. 2011, 12: 901-910. 10.1038/embor.2011.157.PubMed CentralPubMedView ArticleGoogle Scholar
- Tschopp J, Schroder K: NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production?. Nat Rev Immunol. 2010, 10: 210-215. 10.1038/nri2725.PubMedView ArticleGoogle Scholar
- Nakahira K, Haspel JA, Rathinam VA, Lee SJ, Dolinay T, Lam HC, Englert JA, Rabinovitch M, Cernadas M, Kim HP, Fitzgerald KA, Ryter SW, Choi AM: Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol. 2011, 12: 222-230.PubMed CentralPubMedView ArticleGoogle Scholar
- Hoogenraad NJ, Ward LA, Ryan MT: Import and assembly of proteins into mitochondria of mammalian cells. Biochim Biophys Acta. 2002, 1592: 97-105. 10.1016/S0167-4889(02)00268-9.PubMedView ArticleGoogle Scholar
- Haynes CM, Petrova K, Benedetti C, Yang Y, Ron D: ClpP mediates activation of a mitochondrial unfolded protein response in C. elegans. Dev Cell. 2007, 13: 467-480. 10.1016/j.devcel.2007.07.016.PubMedView ArticleGoogle Scholar
- Nargund AM, Pellegrino MW, Fiorese CJ, Baker BM, Haynes CM: Mitochondrial import efficiency of ATFS-1 regulates mitochondrial UPR activation. Science. 2012, 337: 587-590. 10.1126/science.1223560.PubMed CentralPubMedView ArticleGoogle Scholar
- Durieux J, Wolff S, Dillin A: The cell-non-autonomous nature of electron transport chain-mediated longevity. Cell. 2011, 144: 79-91. 10.1016/j.cell.2010.12.016.PubMed CentralPubMedView ArticleGoogle Scholar
- Houtkooper RH, Mouchiroud L, Ryu D, Moullan N, Katsyuba E, Knott G, Williams RW, Auwerx J: Mitonuclear protein imbalance as a conserved longevity mechanism. Nature. 2013, 497: 451-457. 10.1038/nature12188.PubMedView ArticleGoogle Scholar
- Randow F, Youle RJ: Self and nonself: how autophagy targets mitochondria and bacteria. Cell Host Microbe. 2014, 15: 403-411. 10.1016/j.chom.2014.03.012.PubMed CentralPubMedView ArticleGoogle Scholar
- Breitenbach M, Rinnerthaler M, Hartl J, Stincone A, Vowinckel J, Breitenbach-Koller H, Ralser M: Mitochondria in ageing: there is metabolism beyond the ROS. FEMS Yeast Res. 2013, doi:10.1111/1567-1364.12134Google Scholar
- Gomes LC, Scorrano L: Mitochondrial morphology in mitophagy and macroautophagy. Biochim Biophys Acta. 1833, 2013: 205-212.Google Scholar
- Kaelin WG, McKnight SL: Influence of metabolism on epigenetics and disease. Cell. 2013, 153: 56-69. 10.1016/j.cell.2013.03.004.PubMed CentralPubMedView ArticleGoogle Scholar
- Wellen KE, Hatzivassiliou G, Sachdeva UM, Bui TV, Cross JR, Thompson CB: ATP-citrate lyase links cellular metabolism to histone acetylation. Science. 2009, 324: 1076-1080. 10.1126/science.1164097.PubMed CentralPubMedView ArticleGoogle Scholar
- Shyh-Chang N, Locasale JW, Lyssiotis CA, Zheng Y, Teo RY, Ratanasirintrawoot S, Zhang J, Onder T, Unternaehrer JJ, Zhu H, Asara JM, Daley GQ, Cantley LC: Influence of threonine metabolism on S-adenosylmethionine and histone methylation. Science. 2013, 339: 222-226. 10.1126/science.1226603.PubMed CentralPubMedView ArticleGoogle Scholar
- Wang J, Alexander P, McKnight SL: Metabolic specialization of mouse embryonic stem cells. Cold Spring Harb Symp Quant Biol. 2011, 76: 183-193. 10.1101/sqb.2011.76.010835.PubMedView ArticleGoogle Scholar
- Xiong Y, Guan KL: Mechanistic insights into the regulation of metabolic enzymes by acetylation. J Cell Biol. 2012, 198: 155-164. 10.1083/jcb.201202056.PubMed CentralPubMedView ArticleGoogle Scholar
- Hardie DG, Ross FA, Hawley SA: AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol. 2012, 13: 251-262. 10.1038/nrm3311.PubMedView ArticleGoogle Scholar
- Antonioli L, Blandizzi C, Pacher P, Hasko G: Immunity, inflammation and cancer: a leading role for adenosine. Nat Rev Cancer. 2013, 13: 842-857. 10.1038/nrc3613.PubMedView ArticleGoogle Scholar
- Colgan SP, Eltzschig HK: Adenosine and hypoxia-inducible factor signaling in intestinal injury and recovery. Annu Rev Physiol. 2012, 74: 153-175. 10.1146/annurev-physiol-020911-153230.PubMedView ArticleGoogle Scholar
- Friedman JR, Nunnari J: Mitochondrial form and function. Nature. 2014, 505: 335-343. 10.1038/nature12985.PubMed CentralPubMedView ArticleGoogle Scholar
- Campello S, Scorrano L: Mitochondrial shape changes: orchestrating cell pathophysiology. EMBO Rep. 2010, 11: 678-684. 10.1038/embor.2010.115.PubMed CentralPubMedView ArticleGoogle Scholar
- Al-Mehdi AB, Pastukh VM, Swiger BM, Reed DJ, Patel MR, Bardwell GC, Pastukh VV, Alexeyev MF, Gillespie MN: Perinuclear mitochondrial clustering creates an oxidant-rich nuclear domain required for hypoxia-induced transcription. Sci Signal. 2012, 5: ra47-PubMed CentralPubMedView ArticleGoogle Scholar
- Chan DC: Fusion and fission: interlinked processes critical for mitochondrial health. Annu Rev Genet. 2012, 46: 265-287. 10.1146/annurev-genet-110410-132529.PubMedView ArticleGoogle Scholar
- Kasahara A, Cipolat S, Chen Y, Dorn GW, Scorrano L: Mitochondrial fusion directs cardiomyocyte differentiation via calcineurin and Notch signaling. Science. 2013, 342: 734-737. 10.1126/science.1241359.PubMedView ArticleGoogle Scholar
- Hoppins S, Nunnari J: Mitochondrial dynamics and apoptosis–the ER connection. Science. 2012, 337: 1052-1054. 10.1126/science.1224709.PubMedView ArticleGoogle Scholar
- Rizzuto R, Pinton P, Carrington W, Fay FS, Fogarty KE, Lifshitz LM, Tuft RA, Pozzan T: Close contacts with the endoplasmic reticulum as determinants of mitochondrial Ca2+ responses. Science. 1998, 280: 1763-1766. 10.1126/science.280.5370.1763.PubMedView ArticleGoogle Scholar
- van Vliet AR, Verfaillie T, Agostinis P: New functions of mitochondria associated membranes in cellular signaling. Biochim Biophys Acta. 2014Google Scholar
- Nunnari J, Suomalainen A: Mitochondria: in sickness and in health. Cell. 2012, 148: 1145-1159. 10.1016/j.cell.2012.02.035.PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.